Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Defining treatment refractoriness in schizophrenia.

H D Brenner1, S J Dencker, M J Goldstein

  • 1Department of Theoretical and Evaluative Psychiatry, University of Bern, Switzerland.

Schizophrenia Bulletin
|January 1, 1990
PubMed
Summary

This study addresses antipsychotic drug refractoriness in schizophrenia. It aims to define treatment resistance and explore therapies for refractory patients, crucial for improving care for a significant patient minority.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Graves as places of remembrance: on the postwar phase of the Herero war].

Sozialwissenschaftliche Informationen·2012
Same author

Office management of anxiety States.

Canadian family physician Medecin de famille canadien·2011
Same author

The Doctor's and the Patient's Problems in Treating Obesity.

Canadian family physician Medecin de famille canadien·2011
Same author

Crocks: expensive crockery.

Canadian family physician Medecin de famille canadien·2010
Same author

The coronary patient: a psychosocial glimpse.

Canadian family physician Medecin de famille canadien·2010
Same author

Optoacoustic measurement of HCI specific absorption coefficients at DF laser wavelengths.

Applied optics·2010

Area of Science:

  • Neuropsychopharmacology
  • Psychiatry
  • Clinical Psychology

Background:

  • A significant minority of schizophrenia patients exhibit refractoriness to antipsychotic drug therapy.
  • Understanding treatment resistance is critical for improving patient outcomes.

Purpose of the Study:

  • To clarify the concept of treatment resistance or refractoriness in schizophrenia.
  • To propose criteria for defining and rating treatment refractoriness.
  • To explore therapeutic strategies for treatment-refractory schizophrenia.

Main Methods:

  • Convened an international study group from 1980 to 1988.
  • Discussions and position article development focused on defining treatment refractoriness.

Main Results:

Related Experiment Videos

  • The study group distilled efforts to define treatment refractoriness in schizophrenia.
  • Key objectives included conceptual clarification and criteria development.

Conclusions:

  • Defining treatment refractoriness is a necessary first step towards effective interventions.
  • Further research is needed to develop and validate criteria and therapies.